MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014.
Published March 11, 2026 · Recall initiated: February 18, 2026
Summary
FDA records drug Class II recall D-0386-2026, published March 11, 2026 and initiated February 18, 2026. Recalling firm: HTO Nevada Inc. dba Kirkman; Status: Ongoing; Reported quantity: 178 bottles; Lot: Lot #: 807CP-0003, Exp. Date 07/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Stability Data Does Not Support Expiry Date.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- HTO Nevada Inc. dba Kirkman
- Distributor
- Nationwide within the U.S
- Lot
- Lot #: 807CP-0003, Exp. Date 07/31/2026.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: DermalMarch 11, 2026
- FDAMAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By:March 11, 2026
- FDAProduct label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: RisingMarch 11, 2026
- FDASILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, ChinaMarch 11, 2026
- FDAMidodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged andMarch 11, 2026
- FDASodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317,March 11, 2026
Questions about this recall
Was MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014. recalled?
Yes. FDA published recall D-0386-2026 on March 11, 2026. Reported hazard: Stability Data Does Not Support Expiry Date.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail